Anzeige
Mehr »
Login
Freitag, 14.03.2025 Börsentäglich über 12.000 News von 691 internationalen Medien
Riesige Kupfer-Anomalie entdeckt! Ist das der nächste Explorations-Jackpot?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Medien-Archiv vom 13.03.2025

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
DoUSA Rare Earth and Inflection Point Acquisition Corp. II Announce Closing of Business Combination and Upsized PIPE Funding18STILLWATER, Okla., March 13, 2025 (GLOBE NEWSWIRE) -- USA Rare Earth, Inc. ("USARE" or the "Company"), a company building out a domestic rare earth magnet supply chain that includes the mining and...
► Artikel lesen
DoKH Group Plc: Insider information: KH Group has initiated a sale process for Indoor Group and publishes preliminary results for 20248KH Group PlcInsider information 13 March 2025 at 10.00 p.m. EET Insider information: KH Group has initiated a sale process for Indoor Group and publishes preliminary results for 2024 KH Group Plc ("KH...
► Artikel lesen
DoHaivision Systems Inc.: Haivision Announces Results for the Three Months Ended January 31, 202520MONTREAL, March 13, 2025 /PRNewswire/ - Haivision Systems Inc. ("Haivision" or the "Company") (TSX: HAI), a leading global provider of mission critical, real-time...
► Artikel lesen
DoArena Investors, LP: Charge Enterprises Appoints Spencer Bolgard as Chief Executive Officer29NEW YORK, March 13, 2025 /PRNewswire/ -- Charge Enterprises, a leading electrical, broadband, and electric vehicle (EV) charging infrastructure company, is pleased...
► Artikel lesen
DoPangaea Logistics Solutions Ltd. Reports Financial Results for the Three Months and Year Ended December 31, 202425NEWPORT, R.I., March 13, 2025 /PRNewswire/ -- Pangaea Logistics Solutions Ltd. ("Pangaea" or the "Company") (NASDAQ: PANL), a global provider of comprehensive...
► Artikel lesen
DoPreformed Line Products Announces Fourth Quarter 2024 Financial Results21CLEVELAND, March 13, 2025 /PRNewswire/ -- Preformed Line Products Company (NASDAQ: PLPC) today reported financial results for its fourth quarter of 2024 and...
► Artikel lesen
DoDrilling Tools International Corp. Reports 2024 Year End and Fourth Quarter Results23Expects Continued Growth in 2025 Consolidated Revenue, Adjusted EBITDA and Adjusted Free Cash Flow International Revenue Projected to Grow Significantly in 2025 ...
► Artikel lesen
DoIntensity Therapeutics Inc.: Intensity Therapeutics Reports 2024 Year End Financial Results and Provides Corporate Update2132 sites are currently contracted in the INVINCIBLE-3 Study, and 25 patients have been screened Eight Swiss sites are activated in the INVINCIBLE-4 Study, and...
► Artikel lesen
DoPurple Innovation, LLC: Purple Innovation Reports Fourth Quarter and Full Year 2024 Results24Returned to Positive Adjusted EBITDA and Cash Flow in Fourth QuarterGAAP Gross Margin of 42.9% in Q4; Adjusted Gross Margin improved Over 810bps in Q4 Versus Last...
► Artikel lesen
DoDocusign, Inc.: Docusign Announces Fourth Quarter and Fiscal Year 2025 Financial Results29SAN FRANCISCO, March 13, 2025 /PRNewswire/ -- Docusign, Inc. (NASDAQ: DOCU) today announced results for its fourth quarter and fiscal year ended January 31,...
► Artikel lesen
DoEnliven Therapeutics, Inc.: Enliven Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update21Updated Phase 1 data for ELVN-001 expected mid-2025 as positive enrollment momentum continues Expected monotherapy and combination data from the ELVN-002 Phase 1...
► Artikel lesen
DoRegulus Therapeutics Inc.: Regulus Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Recent Updates14Positive topline results from an interim analysis of the fourth cohort of patients in the Phase 1b multiple-ascending dose (MAD) clinical trial of farabursen (RGLS8429)...
► Artikel lesen
DoREGENXBIO Inc.: REGENXBIO Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Operational Updates19Biologics Licensing Application (BLA) for clemidsogene lanparvovec (RGX-121) submitted and on track for potential FDA approval 2H 2025; strategic partnership with...
► Artikel lesen
DoVuzix Corporation: Vuzix Reports 4Q and Full Year 2024 Financial Results28ROCHESTER, N.Y., March 13, 2025 /PRNewswire/ -- Vuzix® Corporation (NASDAQ: VUZI) ("Vuzix" or the "Company"), a leading supplier of AI-driven smart glasses,...
► Artikel lesen
DoEmeren Group Ltd: Emeren Announces Fourth Quarter and Full Year 2024 Financial Results35- Delivered Strong Free Cash Flow in Q4 2024- Achieved High-Margin Expansion Driven by IPP and DSA Businesses NORWALK, Conn., March 13, 2025 /PRNewswire/ --...
► Artikel lesen
DoStandard Dental Labs Inc. Announces Name Change, Ticker Symbol Change, and Reverse Stock Split25ORLANDO, Fla., March 13, 2025 /PRNewswire/ -- Standard Dental Labs Inc. (the "Company" or "SDL") (OTCMKTS: TUTH), a growing force in the dental prosthetics sector, is pleased to announce...
► Artikel lesen
DoMelcor Developments Ltd.: Melcor Developments announces results for 2024, declares $0.11 per share dividend37EDMONTON, Alberta, March 13, 2025 (GLOBE NEWSWIRE) -- Melcor Developments Ltd. (TSX: MRD), an Alberta-based real estate development and asset management company, today reported results for the fourth...
► Artikel lesen
DoTree Island Steel Ltd.: Tree Island Steel Announces Full Year 2024 Results42VANCOUVER, British Columbia, March 13, 2025 (GLOBE NEWSWIRE) -- Tree Island Steel ('Tree Island' or the 'Company') (TSX: TSL) announced today its financial results for the year ended December 31,...
► Artikel lesen
DoBlue Moon Metals Inc: Blue Moon Announces Resumption of Trading, Graduation to Tier 1 on the TSX Venture Exchange and Completion of Share Consolidation Following Transformational Acquisitions42TORONTO, March 13, 2025 (GLOBE NEWSWIRE) -- Blue Moon Metals Inc. ("Blue Moon" or the "Company") (TSXV: MOON) is pleased to announce that its common shares (the "Blue Moon Shares") will resume trading...
► Artikel lesen
DoCellectis Reports Financial Results for the Fourth Quarter and Full Year 2024 and Provides a Business Update54? UCART22 Phase 1 dataset and late-stage development strategy expected in the third quarter of 2025; Orphan Drug Designation (ODD) and Rare Pediatric Disease Designation (RPDD) granted by FDA and...
► Artikel lesen
Seite:  Weiter >>